Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths.
Incyte advances its Opzelura eczema campaign with a ‘reimagine’ theme
Incyte’s newest campaign for Opzelura (ruxolitinib) encourages itchy patients to “Reimagine Relief” as it works to carve out a niche in the crowded eczema treatment
September 21, 2023